No prior pelvic radiation therapy
Any prior pelvic radiation
Patients who have received prior pelvic radiation or cytotoxic chemotherapy
Previous pelvic radiation for prostate cancer.
Plans for pelvic radiation while participating in the study
Previous pelvic radiation for prostate cancer.
Previous pelvic radiation
Patients with any prior pelvic radiation therapy.
Radiation therapy =< 28 days prior to registration; Note: patients with prior pelvic radiation therapy > 54 Gy are ineligible
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
Prior pelvic radiation
Previous pelvic radiation affecting >= 25% of the bone marrow; patients who received whole pelvic radiation are excluded
Patients who had pelvic radiation within 12 months
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
Previous pelvic radiation for prostate cancer
Previous chemotherapy or pelvic radiation therapy
No prior pelvic radiation
Previous pelvic radiation for any reason.
Prior pelvic radiation
Any therapeutic pelvic radiation
Subjects must not have had prior pelvic radiation therapy
History of prior pelvic radiation therapy
No prior pelvic radiation therapy or chemotherapy
Previous systemic chemotherapy (for any cancer) or pelvic radiation therapy
Previous pelvic radiation for bladder or prostate cancer if performed < 12 months prior to enrollment into the study
No previous history of pelvic radiation
Patients with a history of prior whole pelvic radiation
Pelvic radiation therapy
Patients who have received prior pelvic radiation
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
Prior history of pelvic radiation therapy
Previous pelvic radiation for prior cancer
Previous pelvic radiation therapy
Prostate pelvic radiation within the past 12 months
Prior pelvic radiation therapy
An oncology research protocol requiring full pelvic radiation (i.e., 4-field box technique)
Patient must not have had radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
History of pelvic radiation
Patients must be considered able to tolerate systemic chemotherapy and pelvic radiation therapy
Previous pelvic radiation therapy
Radiation therapy to more than 25% of the bone marrow (note: whole pelvic radiation is considered to be over 25%)
Have had previous radiation of the pelvic area
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
No prior radiation to bladder or pelvic region
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
Patients with any prior history of whole pelvic radiation therapy (WPRT)
Patients who have had previous pelvic radiation treatment
Radiation therapy to more than 25% of the bone marrow; whole pelvic radiation is considered to be over 25%
History of pelvic radiation
Prior pelvic radiation
Prior pelvic radiation for any reason
History of pelvic or rectal radiation therapy
Patients who have received any prior pelvic radiation therapy in the area of the tumor that precludes the delivery of a curative dose of pelvic radiation
Prior pelvic radiation
Patients who are referred with pelvic symptoms, a known pelvic mass, or a history of prior radiation, will be excluded from this investigation
Prior pelvic surgery or radiation
History of prior pelvic radiation
Prior history of pelvic radiation
Has received prior pelvic radiation therapy
